期刊文献+

非酒精性脂肪性肝病患者外周血Ghrelin、脂联素与炎性细胞因子检测的临床意义 被引量:3

Clinical significances of detection of Ghrelin,adiponectin and inflammatory cytokines in peripheral blood of patients with NAFLD
下载PDF
导出
摘要 目的:探讨非酒精性脂肪性肝病(NAFLD)患者外周血Ghrelin、脂联素及炎性细胞因子表达水平与NAFLD发生及肝脏损害程度的关系及临床意义。方法:NAFLD组50例(单纯性脂肪肝患者30例,脂肪性肝炎患者20例)、脂肪肝并发糖耐量减低(IGT)组10例、脂肪肝并发血脂异常组20例均为本科住院患者,另选取本院体检中心体检者20例作为健康对照组。采用酶联免疫吸附实验(ELISA)检测各组血浆中Ghrelin、脂联素、胰岛素及TNF-α水平,并进行相关性分析。结果:NAFLD组患者外周血Ghrelin及脂联素表达均低于对照组(P<0.01),TNF-α表达高于对照组(P<0.01);脂联素与TNF-α、体质量指数(BMI)和胰岛素抵抗指数(HOMA-IR)呈负相关(r=-0.811,P<0.01;r=-0.678,P<0.01;r=-0.727,P<0.01),与Ghrelin呈正相关(r=0.836,P<0.01)。结论:Ghrelin、脂联素和炎性细胞因子等在胰岛素敏感性和炎症方面有拮抗作用,这些细胞因子系统的失衡是NAFLD发病及病情进展的关键因素。 Objective To explore the relationships between the expressions of Ghrelin,adiponectin,TNF-α in the peripheral blood of the patients with non-alcoholic fatty liver disease(NAFLD)and occurrence and development of NEFLD and clinical significances.Methods 50 patients with NAFLD(including 30 cases of simple fatty liver and 20 cases of fatty hepatitis),10 patients with fatty liver and impaired glucose tolerance(IGT),20 cases of fatty liver and dyslipidemia were selected,and 20 healthy subjects were used as control group.The expressions of Ghrelin,adiponectin,insulin and TNF-α in the peripheral blood of the patients and healthy subjects were detected with ELASI.Results The expressions of Ghrelin and adiponectin in all experimental groups were significantly lower than those in control group(P〈0.01);The expression of TNF-α in all experimental groups were higher than that in control group(P〈0.01);adiponectin was negatively correlated with TNF-α,BMI and HOMA-IR(r=-0.811,P〈0.01;r=-0.678.P〈0.01;r=-0.727.P〈0.01),but positively correlated with Ghrelin(r= 0.836,P〈0.01).Conclusion Ghrelin and adiponectin play important roles in the occurrence and development of NAFLD.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2010年第4期721-726,共6页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅科研基金资助课题(20060416-4)
关键词 GHRELIN 脂联素 非酒精性脂肪性肝病 Ghrelin adiponectin non-alcoholic fatty liver disease
  • 相关文献

参考文献14

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 2迟家敏.代谢综合征与血脂代谢异常[J].中华老年医学杂志,2006,25(7):553-553. 被引量:6
  • 3Xu A, Wang Y, Hussila K, et al. The fat-derived hormone adiponectin alleviates al-coholic and nonalcoholic fatty liver diseases in mice [J]. Clin Invest, 2003, 112 (1): 91-100.
  • 4黄宇虹,高秀梅,张伯礼.脂联素的研究进展[J].中国临床药理学与治疗学,2004,9(9):961-965. 被引量:17
  • 5Scheen AJ. Pathophysiology of type 2 diabetes [J]. Acta Clin Belg, 2003, 58 (6): 335-341.
  • 6Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30 kDa adi-pocyte comp lement-related protein increases fatty acid oxidation in muscle and causes weight lose in mice [J]. Proe Natl Acad Sci USA, 2001, 98 (4) : 2005 2010.
  • 7HottaK, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocytep rotein adiponectin are decreased in parallel with reduced insulin sensitivity during thep rogression to type 2 diabetes in rhesus monkeys [J].Diabetes, 2001, 50 ( 5 ): 1126-1133.
  • 8Matsuda M, Shimomura I, Sata M, et al. Role of adiponeetin in preventing vascular stenosis. The missing link of adipo-vascular axis [J]. J Biol Chem, 2002, 277: 37487- 37491.
  • 9Kojiraa M, Hosoda H, Date Y, et al. Ghrelin is a growth- hormone releasing aeylated peptide from stomach [J]. Nature, 1999, 402 (6762): 656.
  • 10金珍婧,田月丽,李东复,王永勤.慢性肝病患者外周血Ghrelin与炎性细胞因子的水平检测及其相关性研究[J].中国免疫学杂志,2009,25(12):1129-1132. 被引量:3

二级参考文献90

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 3[1]Scheen AJ. Pathophysiology of type 2 diabetes [ J]. Acta Clin Belg, 2003; 58(6): 335-41
  • 4[2]Takahashi M, Arita Y, Yamagata K. Genomic structure and mutations in adipose-specific gene, adiponectin[J]. Int J Obse, 2000; 24: 861- 8
  • 5[3]Saito K, Tobe T, Minoshima. Organization of the gene for gelatin-binding protein(GBP28) [J]. Gene, 1999; 229( 1 - 2): 67- 73
  • 6[4]Hare K, Boutin P, Mori Y. Genetic variation in the gene encoding adiponectin is associated risk of type 2 diabetes in the Japanese population[J]. Diabetes, 2002; 51(4): 1294
  • 7[5]Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T,Sumitsuji S, et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease[J]. J Am Coll Cardiol, 2004; 43(7): 1195-200
  • 8[6]Vasseur F, Helbecque N, Dina C. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipoctye-secreted adiponectin hormone levels and contributes to the genetic risk for type 2 diabetes in French Caucasians[J]. Hum Mol Genet, 2002; 11(21):2607 - 14
  • 9[7]Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, et al. Adiponectin acts in the brain to decrease body weight[J]. Nat Med, 2004; 10(5): 524- 9
  • 10[8]Furukawa K, Hori M, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, et al. Adiponectin down-regulates acylcoenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages[J]. Biochem Biophys Res Commun, 2004; 317(3): 831 - 6

共引文献1541

同被引文献43

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部